Format

Send to

Choose Destination
BMJ. 2017 May 2;357:j1855. doi: 10.1136/bmj.j1855.

US drug marketing: how does promotion correspond with health value?

Author information

1
Yale University School of Medicine, New Haven, Connecticut, USA.
2
Section of General Internal Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut, USA joseph.ross@yale.edu.
3
Department of Health Policy and Management, Yale University School of Public Health.
4
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.
PMID:
28465309
DOI:
10.1136/bmj.j1855
[Indexed for MEDLINE]

Conflict of interest statement

Competing interests: We have read and understood BMJ policy on declaration of interests and declare that JSR receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing; from Medtronic and the FDA to develop methods for post-market surveillance of medical devices; from FDA to establish a Center for Excellence in Regulatory Science and Innovation; from the Blue Cross Blue Shield Association (BCBSA) to better understand medical technology evidence generation; from the Centers of Medicare and Medicaid Services to develop and maintain performance measures that are used for public reporting; and from the Laura and John Arnold Foundation to support the Collaboration on Research Integrity and Transparency at Yale.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center